Company profile for Adial Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder “AUD” using our lead investigational new drug product, AD04. A Phase 2b University of Virginia investigator sponsored clinical trial of AD04 for the treatment of AUD showed promising results and no overt safety concerns (there were no statistically significant serio...
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder “AUD” using our lead investigational new drug product, AD04. A Phase 2b University of Virginia investigator sponsored clinical trial of AD04 for the treatment of AUD showed promising results and no overt safety concerns (there were no statistically significant serious adverse events reported). The Company plans to commence a Phase 3 clinical trial using AD04 for the potential treatment of AUD in subjects with certain target genotypes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1001 Research Park Blvd, Ste 100 Charlottesville, VA 22911
Telephone
Telephone
(434) 422-9800
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/26/3195096/26135/en/Adial-Pharmaceuticals-Announces-a-Warrant-Inducement-Transaction-for-Approximately-2-86-Million-in-Gross-Proceeds.html

GLOBENEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/14/3188326/26135/en/Adial-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/10/17/3168634/26135/en/Adial-Pharmaceuticals-CEO-was-a-Featured-Guest-on-The-Big-Biz-Show.html

GLOBENEWSWIRE
17 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164125/26135/en/Adial-Pharmaceuticals-Partners-with-Genomind-for-Precision-Medicine-Testing-Solution.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/09/16/3150713/26135/en/Adial-Pharmaceuticals-Provides-Business-Update-Following-Favorable-Comments-from-FDA-End-of-Phase-2-EOP2-Meeting-for-AD04.html

GLOBENEWSWIRE
16 Sep 2025

https://www.globenewswire.com/news-release/2025/08/20/3136402/26135/en/Adial-Pharmaceuticals-Encouraged-By-U-S-Senate-Support-for-Expanded-Clinical-Trial-Endpoints-Beyond-Abstinence-in-Alcohol-and-Substance-Use-Disorder-Treatments.html

GLOBENEWSWIRE
20 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty